XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Basis of Presentation (Details) - USD ($)
$ in Thousands
Feb. 20, 2020
Sep. 30, 2024
Dec. 31, 2023
Business Acquisition [Line Items]      
Business combination, consideration transferred, equity interests issued (in shares) 26,844,877    
Business combination common stock under contingent value right (in shares) 86,630,633    
Contingent consideration liabilities   $ 1,294 $ 2,700
Progenics      
Business Acquisition [Line Items]      
Aggregate cash payments percentage 40.00%    
Percentage of total contingent consideration under CVRs 19.90%    
Business combination contingent value right of total consideration $ 99,600    
Progenics | Cash Payments 2022      
Business Acquisition [Line Items]      
Contingent consideration liabilities 100,000    
Progenics | Cash Payments 2023      
Business Acquisition [Line Items]      
Contingent consideration liabilities $ 150,000